GMRE - NYSE
Global Medical REIT Inc.
$35.74
-1.2%Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
At a Glance
Live SnapshotGlobal Medical REIT Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Cash Flow Quality Insight
Cash flow concerns: Despite profitability, the company is burning cash. Review working capital management, CapEx levels, and sustainability of current operations.
Global Medical REIT Inc. Cash Flow Statement
GMRE • NYSE
| Global Medical REIT Inc. Cash Flow Statement | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Aug 2014 | Aug 2013 | Aug 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||||||||
6.6M | 20.6M | 20M | 18.3M | -2.5M | 9.6M | 14.6M | -87K | -6.4M | -1.6M | -652.2K | -45.3K | -50.1K | |
56.1M | 59M | 57.7M | 47.3M | 36.8M | 25.5M | 18M | 10.1M | 2.4M | 659.7K | 129.1K | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | 963K | 0.0 | -7.7M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
5.1M | 4.2M | 4.7M | 5.8M | 5.3M | 3.3M | 2.7M | 1.8M | 1.7M | 0.0 | 0.0 | 0.0 | 0.0 | |
1M | -9.7M | -4.1M | 1.3M | 1.6M | 1.8M | 1.8M | 1.5M | 350.4K | 126.5K | 26.4K | 11.5K | 15K | |
1.2M | -5.7M | -1.7M | -3.8M | -7.6M | -3.8M | -4.4M | -1.7M | -781K | 614.2K | 350.4K | 11.5K | 15K | |
70M | 68.4M | 76.5M | 69M | 34.5M | 36.4M | 24.8M | 11.6M | -2.7M | -208.8K | -146.3K | -33.8K | -35.1K | |
INVESTING ACTIVITIES | |||||||||||||
(0.0) | (0.0) | -150.9M | -192.3M | -218.8M | -256.8M | -180.8M | -252.2M | -150.5M | -32.2M | -21.9M | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | -5.1M | (0.0) | (0.0) | (0.0) | -140.4K | (0.0) | (0.0) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | -1.5M | -1.7M | -373K | -426K | -797.8K | -385.1K | (0.0) | (0.0) | (0.0) | |
57.6M | 0.0 | 0.0 | 0.0 | 208K | 0.0 | 24M | 21K | 242K | 0.0 | 0.0 | 0.0 | 0.0 | |
-103.6M | 67.6M | 13.7M | -2.4M | 1.5M | 293K | 5.3M | -433K | 242K | -32.3M | -14.9K | 0.0 | 0.0 | |
-45.9M | (67.6M) | -137.3M | -194.7M | -223.7M | -258.2M | -151.6M | -252.7M | -150.4M | -32.3M | -21.9M | (0.0) | (0.0) | |
FINANCING ACTIVITIES | |||||||||||||
10.9M | 0.0 | 9.9M | 205.5M | 53.1M | 0.0 | 37M | 33.8M | 137.3M | 0.0 | 0.0 | 25K | 0.0 | |
32.7M | -86.1M | 121.9M | -10.6M | 188.2M | 0.0 | 115.4M | 136.8M | 33M | 42.3M | 2.7M | 0.0 | 0.0 | |
-65.7M | -64.8M | -64.2M | -58.3M | -45.8M | -35M | -24.8M | -16M | -3.9M | -255.6K | -42.6K | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -263K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
252K | 7.1M | -5.2M | -8.9M | -2.8M | 259.1M | -3.1M | -3.1M | -2.9M | -389.1K | 19.6M | 0.0 | 0.0 | |
-21.9M | -143.8M | 62.4M | 127.7M | 192.7M | 224.1M | 124.5M | 226.5M | 163.6M | 41.6M | 22.2M | 25K | 0.0 | |
CASH FLOW SUMMARY | |||||||||||||
2.2M | -7.7M | 1.7M | 2M | 3.6M | 2.3M | -2.3M | -14.6M | 10.5M | 9.1M | 159.5K | -8.8K | -35.1K | |
6.7M | 14.5M | 12.8M | 10.8M | 7.2M | 4.8M | 7.1M | 19.7M | 9.2M | 88.8K | 3.5K | 12.3K | 47.4K | |
8.9M | 6.7M | 14.5M | 12.8M | 10.8M | 7.2M | 4.8M | 5.1M | 19.7M | 9.2M | 163K | 3.5K | 12.3K | |
-25.1M | 58.4M | -79.7M | -132.7M | -184.3M | -220.4M | -156M | -240.6M | -153.2M | -32.4M | -22M | -33.8K | -35.1K |
SEC Filings
GMRE - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | March 03, 2026 | March 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 02, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 26, 2026 | January 23, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 04, 2025 | December 03, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 18, 2025 | November 13, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 13, 2025 | November 13, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 05, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 04, 2025 | November 04, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 08, 2025 | October 08, 2025 | 2025 |
Related Guides
Continue your GMRE research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.